INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Biogen Inc. with Losses to Contact the Firm
29 mai 2024 12h30 HE
|
Schall Law
The Schall Law Firm Encourages Investors in Biogen Inc. with Losses to Contact the Firm
BIOGEN ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Biogen Inc. and Encourages Investors to Contact the Firm
28 mai 2024 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, May 28, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against...
BIOGEN INC. (NASDAQ: BIIB) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Biogen Inc. Investors of Upcoming Deadline
28 mai 2024 14h30 HE
|
Bernstein Liebhard LLP
Bernstein Liebhard LLP Reminds Biogen Inc. Investors of Upcoming Deadline
BIOGEN ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Biogen Inc. and Encourages Investors to Contact the Firm
24 mai 2024 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, May 24, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Biogen...
BIOGEN INC. (NASDAQ: BIIB) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Biogen Inc.
24 mai 2024 12h30 HE
|
Bernstein Liebhard LLP
BIOGEN INC. (NASDAQ: BIIB) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Biogen Inc.
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Biogen Inc. with Losses to Contact the Firm
23 mai 2024 15h48 HE
|
Schall Law
The Schall Law Firm Encourages Investors in Biogen Inc. with Losses to Contact the Firm
BIOGEN ALERT: Bragar Eagel & Squire, P.C. is Investigating Biogen Inc. on Behalf of Biogen Stockholders and Encourages Investors to Contact the Firm
24 févr. 2024 02h30 HE
|
Bragar Eagel & Squire
NEW YORK, Feb. 24, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Biogen Inc. (“Biogen” or...
Neurologists Report Frustration with Efficacy and Logistical Issues Around Eisai/Biogen’s Leqembi, According to Spherix Global Insights Neurologist Survey
22 févr. 2024 15h04 HE
|
Spherix Global Insights
EXTON, PA, Feb. 22, 2024 (GLOBE NEWSWIRE) -- The 2023 announcement of newly approved disease-modifying therapy (DMT) Leqembi (lecanemab) for Alzheimer’s Disease (AD) sparked eager anticipation...
Spinal Muscular Atrophy Market: Navigating Therapeutic Advances towards USD 5.6 Billion by 2034, with a CAGR of 14.80% - By PMI
15 févr. 2024 17h02 HE
|
PMI
Covina, Feb. 15, 2024 (GLOBE NEWSWIRE) -- “According to the recent research study, the Spinal Muscular Atrophy Market size was valued at about USD 1.4 Billion in 2024 and expected to grow at CAGR of...
Anti-CD20 Monoclonal Antibodies Market Size & Share to Exceed USD 19.8 Billion by 2034, at CAGR of 9.0%. “Revolutionizing Immune Therapies: Unveiling the Global Symphony of Anti-CD20 Monoclonal Antibodies Market” – PMI Leads the Way
01 févr. 2024 20h00 HE
|
PMI
Covina, Feb. 01, 2024 (GLOBE NEWSWIRE) -- “According to the recent research study, the Anti-CD20 Monoclonal Antibodies Market size was valued at about USD 9.0 Billion in 2024 and expected to grow at...